Synaptogenic effect of APP -Swedish mutation in familial Alzheimer’s disease
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Mutations in β-amyloid (Aβ) precursor protein ( APP ) cause familial Alzheimer’s disease (AD) probably by enhancing Aβ peptides production from APP. An antibody targeting Aβ (aducanumab) was approved as an AD treatment; however, some Aβ antibodies have been reported to accelerate, instead of ameliorating, cognitive decline in individuals with AD. Using conditional APP mutations in human neurons for perfect isogenic controls and translational relevance, we found that the APP -Swedish mutation in familial AD increased synapse numbers and synaptic transmission, whereas the APP deletion decreased synapse numbers and synaptic transmission. Inhibition of BACE1, the protease that initiates Aβ production from APP, lowered synapse numbers, suppressed synaptic transmission in wild-type neurons, and occluded the phenotype of APP -Swedish–mutant neurons. Modest elevations of Aβ, conversely, elevated synapse numbers and synaptic transmission. Thus, the familial AD-linked APP -Swedish mutation under physiologically relevant conditions increased synaptic connectivity in human neurons via a modestly enhanced production of Aβ. These data are consistent with the relative inefficacy of BACE1 and anti-Aβ treatments in AD and the chronic nature of AD pathogenesis, suggesting that AD pathogenesis is not simply caused by overproduction of toxic Aβ but rather by a long-term effect of elevated Aβ concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Swedish mutation is pathogenic and is associated with elevated secretion of Aβ and neuronal abnormality [197]”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“The key consequence of the Swedish mutation is thought to be an enhancement of APP cleavage by BACE1, leading to increased A β production (39–40, 49 ), as Chronic treatment of WT human neurons with the BACE1 inhibitor LY2886721 (50–51) suppressed production of A β and of the secreted extracellular…”
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653 · cited 1×
“consistent with increased synaptic function (60).”
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651 · cited 1×
“For example, A β increases Ca 2+ influx in cultured neurons and activates synaptic transmission and presynaptic facilitation in mouse hippocampal cultures and slices (28–31), and A β is required in young rats for memory stabilization (32).”
Rapid single-step induction of functional neurons from human pluripotent stem cells
Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.05.029 · Cited by 1,644 · cited 1×
“S2 for characterization) (45) and infected the developing postmitotic neurons with viruses expressing Flp or Cre recombinase.”
Self-citation
Research works printed but not linked: 26
- 10.1038/sj.emboj.7600061 · DOI · Paper page
- 10.1038/s41591-021-01369-8 · DOI · Paper page
- 10.1007/978-981-32-9358-8_16 · DOI · Paper page
- 10.1523/JNEUROSCI.21-13-04691.2001 · DOI · Paper page
- 10.1016/j.neuron.2016.08.034 · DOI · Paper page
- 10.1523/JNEUROSCI.2009-17.2017 · DOI · Paper page
- 10.1016/j.nbd.2015.10.019 · DOI · Paper page
- 10.1083/jcb.201701045 · DOI · Paper page
- 10.1073/pnas.1614249113 · DOI
- 10.1016/j.neuron.2006.10.035 · DOI · Paper page
- 10.1038/nn.2433 · DOI · Paper page
- 10.1074/jbc.274.42.30322 · DOI · Paper page
- 10.1016/j.cub.2020.02.083 · DOI
- 10.1016/j.molmed.2017.04.001 · DOI
- 10.1016/j.mcn.2015.11.010 · DOI
- 10.1016/j.neuron.2019.07.010 · DOI · Paper page
- 10.1016/j.celrep.2015.03.068 · DOI · Paper page
- 10.1038/s41598-018-20436-8 · DOI
- 10.3389/fnins.2019.01154 · DOI · Paper page
- 10.1523/JNEUROSCI.2994-18.2019 · DOI · Paper page
- 10.1001/jamaneurol.2020.4857 · DOI
- 10.1016/j.neuroscience.2010.04.078 · DOI
- 10.1016/j.cels.2020.11.007 · DOI
- 10.1007/s11064-018-2512-0 · DOI
- 10.1016/j.stem.2015.07.017 · DOI · Paper page
- 10.1172/JCI78612 · DOI
Cited by
Granzotto, A., Vissel, B., & Sensi, S. L. (2024) · eLife · doi:10.7554/elife.90633 · Cited by 71
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Yesiltepe, M., Yin, T., Tambini, M. D., Breuillaud, L., Zehntner, S. P., & D’Adamio, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1040576 · Cited by 6
Metadata
- Authors
- Zhou, B., Lu, J. G., Siddu, A., Wernig, M., & Südhof, T. C.
- Affiliations
- Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA.
- Department of Pathology, Stanford University School of Medicine, 265 Campus Drive, Stanford, CA 94305, USA.
- Venue
- Science Translational Medicine
- Published
- 2022-10-19
- Volume
- 14
- Issue
- 667
- ISSN
- 1946-6234
- 1946-6242
- Cited by
- 106
- References
- 40
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synaptogenic effect of APP -Swedish mutation in familial Alzheimer’s disease. https://app.cochat.ai/papers/10.1126/scitranslmed.abn9380
- The paper
- Zhou, B., Lu, J. G., Siddu, A., Wernig, M., & Südhof, T. C. (2022). Synaptogenic effect of APP -Swedish mutation in familial Alzheimer’s disease. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abn9380
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.